# Immune Response Following Seasonal Influenza Vaccination

> **NCT03163342** · PHASE4 · COMPLETED · sponsor: **Altimmune, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Licensed seasonal influenza vaccine

## Key facts

- **NCT ID:** NCT03163342
- **Lead sponsor:** Altimmune, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-08
- **Primary completion:** 2017-11-21
- **Final completion:** 2018-06-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03163342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03163342, "Immune Response Following Seasonal Influenza Vaccination". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT03163342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*